Advance Treatment Can Delay Onset Of Rheumatoid Arthritis By Years, Trial Data Show

People receiving a year of abatacept (Orencia) injections had onset of rheumatoid arthritis postponed by up to four years, ...
Rheumatology Advisor

One Year of Abatacept Delays Progression to RA for Up to Four Years in At-Risk Population

One-year treatment with abatacept delays progression to rheumatoid arthritis for up to 4 years among at-risk patients.
Nasdaq

U.S. Food and Drug Administration Approves Orencia® (abatacept) in Combination with a Calcineurin Inhibitor and Methotrexate for the Prevention of Acute Graft Versus Host ...

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY): U.S. Food and Drug Administration Approves Orencia® (abatacept) in Combination with a Calcineurin Inhibitor and Methotrexate for the ...
Healio

Abatacept, adalimumab yield ‘identical’ responses in early rheumatoid arthritis

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Patients in early rheumatoid arthritis respond well to either abatacept or adalimumab, with the ...
MedPage Today

Case Study: RA Patient Develops Rare Reaction Related to Biologic Treatment

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window "Medical ...
Healio

S100 protein levels predict abatacept response in juvenile idiopathic arthritis

Please provide your email address to receive an email when new articles are posted on . Lower levels of S100A8/9 and S100A12 proteins were linked to greater improvement in polyarticular JIA with ...
MPR

One Year of Abatacept Delays Progression to RA for Up to 4 Years in At-Risk Population

The between-group difference in restricted mean arthritis-free survival time seen at 2 years persisted at 4 years.